|
Volumn 12, Issue 3, 2002, Pages 341-344
|
Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3';
6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE;
MODIPAFANT;
OZAGREL;
RIDOGREL;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
THROMBOXANE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
MICROSOME;
NONHUMAN;
RABBIT;
THROMBOCYTE;
THROMBOCYTE AGGREGATION INHIBITION;
ANIMALS;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
INDICATORS AND REAGENTS;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET MEMBRANE GLYCOPROTEINS;
RABBITS;
RECEPTORS, CELL SURFACE;
RECEPTORS, G-PROTEIN-COUPLED;
STRUCTURE-ACTIVITY RELATIONSHIP;
THROMBOXANE-A SYNTHASE;
|
EID: 0037059946
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00731-4 Document Type: Article |
Times cited : (16)
|
References (19)
|